AMG 176

Overview

AMG 176 is an MCL-1 inhibitor (myeloid cell leukemia-1) that can prevent cancer cells from creating proteins to protect itself, and can cause cell death.

SparkCures ID 263
Developed By Amgen
Generic Name AMG 176
Treatment Classifications
  • Myeloid Cell Leukemia-1 (MCL-1) Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.